With full membership, watch our educational and editorial videos, search the site, receive our newsletters, join discussions, download slides and much more.
Join Drs Valentin Fuster, Roger Blumenthal, Bob Harrington, Judith Hochman, Sanjay Kaul, Suzanne Oparil, Gregg Stone, Lynne Warner Stevenson, and Bruce Wilkoff as they discuss the results of ARBITER 6-HALTS, the PLATO STEMI subanalysis, the two CHAMPIONs, and CASCADE and tackle the issue of too little, too soon in clinical trials today.
New agents and interventions are paving the way for revised modalities in the management of patients with atrial fibrillation. Join Drs Alpert and Delascio Lopes for a review of the latest findings and options.
Raised in a blue-collar neighborhood of Somerville, MA, Dr Bob Harrington was blessed to have a strong family and the Jesuits on his side as he traveled from "Yankee" Boston to Duke University. Join him as he tells his story to Dr Rob Califf.
How do regulatory pathways differ in the US and UK? Drs Harrington, Bhatt, and Cleland share their experiences and offer insight on how to support innovative research.
Dr Melissa Walton-Shirley talks to Dr Nassir Marrouche about the results of RE-LY, the impact of dronedarone on the treatment of atrial fibrillation, and his hopes for the future of MRI-guided ablation.
Join heartwire's Lisa Nainggolan as she talks to DrsFranz Messerli and Melissa Walton-Shirley about the results of the KYOTO HEART Study, what they mean for North American and European populations, and the future role of angiotensin-receptor blockers (ARBs).
With the ISIS-1 trial, Dr Peter Sleight and his team at Oxford changed the approach to cardiovascular research. Join Dr Robert Califf as he talks to Dr Sleight about his journey from London to San Francisco to Oxford and finally to Italy, where he discovered the music of the heart.
Drs Bonhoeffer and Kovac discuss size, sterility, location, presence of multidisciplinary teams, and imaging techniques - issues to consider in creating an ideal lab that can also adapt to future technologies and developments.
Join 'heartwire's Steve Stiles as he talks to Drs Nassir Marrouche and Clyde Yancy about MADIT-CRT, the potential benefits and costs for the heart-failure population in light of the trial, and about why the Europeans seem to be ahead of the guidelines in the European CRT Survey.
Is there an ideal blood-pressure goal? theheart.org's Dr Melissa Walton-Shirley catches up with hypertension expert and current president of the American Society of Hypertension, Dr Henry Black, to address this thorny issue and others.
Exactly three years after the DES firestorm ignited the World Congress of Cardiology in Barcelona, heartwire's Shelley Wood sifts through the ashes with Drs Tony Gershlick, Christian Spaulding, and Renu Virmani in a discussion on DES safety and what we've learned since September 2006.
Dr Robert Califf sits down with Drs Alfred Bove, Jack Lewin, and Clyde Yancy and AHA CEO Nancy Brown to talk about the ACC and the AHA and their role in the debate on healthcare reform.
Dr Valentin Fuster returns to the city where he was born for a scintillating discussion with Drs Fox, Gershlick, Marrouche, Messerli, Spaulding, Vergheugt, Virmani, and Yancy about the miracle of RE-LY and the striking success of ticagrelor in the PLATO study.
Dr Michael Shen joins Dr Frans Wackers, senior investigator of the DIAD trial, for an informative discussion addressing why the trial findings were surprising and what helps to explain the results.
Join Drs Valentin Fuster, William E Boden, and George D Dangas as they discuss the results, plus the evolution of therapy over the last forty years, the mechanisms of coronary artery disease progression in diabetic patients, and what is perhaps one of the most fundamental problems in the field: that patients today are still not treated to target with best medical therapy.
Is it possible and desirable to envisage a nationwide system to screen athletes for hypertrophic cardiomyopathy? Drs Ommen, Maron, and Thompson examine the Italian screening data and review the implications of this model for the US.
Join Dr Robert Califf for a probing and personal interview with Dr Steve Nissen, about his activist days at the University of Michigan and the development of IVUS, to how he ended up at the Cleveland Clinic and what he thinks about the future of medicine in America.
With the global trend leaning toward increased use of transradial access, our international panel reports on standard practice at their respective institutions and the key issues that influence it such as bleeding, access-site complications, stroke risk, patient mobility, and operator experience. Join Drs Kandzari (US), Feres (Brazil), Le May (Canada), and Steg (France) for this thoughtful and practical discussion.
Join Drs Valentin Fuster, Anne Curtis, Timothy Gardner, Barry Greenberg, Cindy Grines, Bob Harrington, Sanjay Kaul, Harlan Krumholz, and Salim Yusuf as they unravel the STICH trial and debate the lessons learned from PROTECT-AF in Part 1 of the Cardiology Show. In Part 2 of the program, the JUPITER trial is back on the table and our experts give their opinion on the polypill following the results of the TIPS study.